SecBot SecBot
ANALYST-UPGRADE ·Filed Aug 20, 2026

MRK

Merck & Co., Inc.
MIXED
Impact 5/10
Horizonmonths Processed2mo ago SECanalyst-MRK-morganst-20260820
2 firms acted on MRK: RBC Capital, Morgan Stanley
Actionable Insight ◆ Mixed

**Traders should treat Morgan Stanley's upgrade as a high-conviction bullish call given the massive PT hike, but the heavy insider selling and mixed institutional flows create a cautionary backdrop. The stock already trades above consensus targets, so upside may be limited unless earnings or pipeline catalysts emerge.**

DirectionMixed
Confidencemedium
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$148.99
T+0 close · Aug 20, 2026 · via day close
Latest settled
−0.83%
T+60 · $147.76
Vs SPY
+0.25%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 20 $148.99entry
  2. T+1 · 3mo ago +2.39%α +1.98% · $152.55
  3. T+5 · 3mo ago +0.37%α −0.75% · $149.54
  4. T+20 · 2mo ago −1.42%α −1.42% · $146.87
  5. T+60 · 4d ago −0.83%α +0.25% · $147.76
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Morgan Stanley upgraded Merck & Co., Inc. (MRK) from Equal-Weight to Overweight on August 20, 2026, with a new price target of $179, a massive 54.3% increase from its prior $116 target. The upgrade is part of a two-firm cluster on MRK, with RBC Capital simultaneously downgrading to Sector Perform (PT $150). Morgan Stanley's call is contrarian to the consensus mean target of $137.73 and median of $142, but aligns with the bullish tilt in consensus (69% Buy/Strong Buy). The firm's 55% accuracy on 4,986 calls is below average among covering firms, and its 43% accuracy on 7 MRK calls is also below average. The stock trades at $152.20, already above the consensus mean and median, implying 17.6% upside to Morgan Stanley's new target. Momentum is mixed: 2 upgrades and 1 downgrade in 30 days, with EPS revisions slightly negative for the current quarter (1 up, 5 down in 30 days). Insider selling is heavy, with five sales totaling ~$14.3M in August, including a $10.7M sale by EVP Zachary Jennifer, which diverges from the bullish analyst signal. The bottom line: Morgan Stanley's bold PT hike is a standout, but the firm's below-average track record on MRK and heavy insider selling warrant caution.

Impact Score

Base Score
4/7
LLM Adjustment
+1
Final Score
5/10

Consensus & Targets

Buy / Strong Buy
25 (69%)
Hold
11
Sell / Strong Sell
0
Total Analysts
26
Mean PT
$137.73
Median PT
$142.00
High PT
$155.00
Low PT
$105.00
Current Price
$152.20
Implied Upside
-9.5%

Consensus is 69% Buy/Strong Buy (9 strong buy, 16 buy), 31% Hold (11 hold), 0% Sell. This is a strongly bullish consensus, with 25 of 36 analysts recommending buying. Morgan Stanley's upgrade aligns with the majority view but is more aggressive on price target.

Current price: $152.20. Consensus mean target: $137.73 (implied downside of -9.5%). Median: $142 (downside -6.7%). High: $155 (upside +1.8%). Low: $105 (downside -31%). Morgan Stanley's new PT of $179 is the highest among all covering analysts, implying 17.6% upside and sitting well above the consensus mean and median.

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-08-20RBC CapitaldowngradeSector Perform$150.00
2026-08-20Morgan StanleyupgradeOverweight$179.00
2026-08-12Daiwa CapitalupgradeOutperform$143.00
2026-08-11Argus ResearchmaintainBuy$145.00
2026-08-05GuggenheimmaintainBuy$146.00
2026-07-29BarclaysmaintainOverweight$150.00
2026-07-13JP MorganmaintainOverweight$140.00
2026-07-13BMO CapitalmaintainOutperform$142.00
2026-07-13GuggenheimmaintainBuy$145.00
2026-07-09Morgan StanleymaintainEqual-Weight$113.00

30-day analyst activity: 2 upgrades (Morgan Stanley, Daiwa Capital) and 1 downgrade (RBC Capital). EPS revisions: current quarter (0q) has 1 up and 5 down in 30 days, with EPS declining from $2.30 to $2.21. Next quarter (+1q) has 2 up and 4 down. Full-year (+1y) has 5 up and 4 down. Overall, estimates are being revised slightly lower for near-term quarters but stable for the full year.

Firm Track Record: Morgan Stanley

Morgan Stanley accuracy: 55% on 4986 calls | avg return: 4.3%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 12 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
Deutsche Bank100%2/29.7%top tier
BMO Capital50%2/40.7%below average
Morgan Stanley43%3/72.8%below average
Wells Fargo40%2/53.8%below average
B of A Securities33%1/3-0.2%below average
Guggenheim25%1/4-7.8%below average
Truist Securities20%1/5-10.3%below average
Cantor Fitzgerald9%1/11-5.5%below average
Barclays0%0/2-7.6%below average
Berenberg0%0/211.6%below average

Morgan Stanley has a 55% accuracy rate on 4,986 calls overall, with an average return of 4.3%. On MRK specifically, they are 3 for 7 (43% accuracy), below average. Among covering firms, Deutsche Bank leads with 100% accuracy on 2 calls (avg return 9.7%), while Cantor Fitzgerald is worst at 9% on 11 calls (avg return -5.5%). Morgan Stanley's call is contrarian to its own below-average track record on MRK.

Earnings Estimates

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
0y$2.75$2.62 to $2.87$67.1B↑13 ↓0
0q$2.21$2.01 to $2.41$17.3B↑2 ↓0
+1y$9.56$8.33 to $10.36$70.3B↑6 ↓0
+1q$1.96$1.86 to $2.09$16.9B↑4 ↓0

Cross-Platform Signals

Insider Trades (90d)
0 buys / 5 sells
Institutional
Zurcher Kantonalbank (Zurich Cantonalbank): add (44.7%)
Institutional
FIRST TRUST ADVISORS LP: trim (-42%)
Institutional
Clearstead Advisors, LLC: trim (-26.1%)
Short Interest
Short: 1,375,251 | Exempt: 2,579 | TRF Vol: 2,420,158 | Short Ratio: 56.8% | Off-exchange volume (dark pool + OTC)

Insider trades: Five sales totaling ~$14.3M in August, including a $10.7M sale by EVP Zachary Jennifer on Aug 12 and a $1.46M sale by EVP DeLuca Richard R. on Aug 12. No insider buys. This is a strong bearish divergence from the bullish analyst signal. Institutional changes are mixed: Zurich Cantonalbank added 44.7% ($190M), while First Trust Advisors trimmed 42% ($333M). Short interest ratio is 56.8%, indicating elevated bearish positioning. No congressional trades reported.

Investment Themes

Documents Analyzed

Report based on filing metadata.

Track record

34 reports on MRK

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +16.92% at T+20 after the Aug 6, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 12, 20264d ago 144 Neutral 2/10 Entry $147.76 Now $144.46 −2.23% settles Feb 11
  2. Nov 9, 20268d ago PTAB Trial Neutral 2/10 Entry $148.05 Now $144.46 −2.42% settles Feb 8
  3. Nov 3, 202613d ago 3 Neutral 2/10 Entry $144.67 Now $144.46 −0.15% settles Feb 1
  4. Nov 3, 202613d ago Institutional Cluster Bearish 4/10 Entry $144.67 Now $144.46 +0.15% settles Feb 1
  5. Nov 2, 202614d ago 144 Neutral 2/10 Entry $144.67 Now $144.46 −0.15% settles Feb 1
  6. Oct 29, 202618d ago 8-K Neutral 5/10 Entry $146.33 Now $144.46 −1.28% settles Jan 27
  7. Oct 22, 202625d ago 3/A Neutral 1/10 Entry $145.27 Now $144.46 −0.56% settles Jan 21
  8. Oct 21, 202627d ago PTAB Trial Neutral 3/10 Entry $147.24 Now $144.46 −1.89% settles Jan 20
  9. Oct 15, 20264w ago PTAB Trial Bullish 6/10 Entry $145.95 Now $144.46 −1.02% settles Jan 13
  10. Oct 15, 20264w ago PTAB Trial Bullish 5/10 Entry $145.95 Now $144.46 −1.02% settles Jan 13
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (11h 29m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 20, 2026